Shopping Cart
Remove All
Your shopping cart is currently empty
SLLK, the control peptide for the TSP1 inhibitor, serves as the counterpart to LSKL.

| Pack Size | Price | USA Warehouse | Global Warehouse | Quantity |
|---|---|---|---|---|
| 10 mg | Inquiry | 10-14 weeks | 10-14 weeks | |
| 50 mg | Inquiry | 10-14 weeks | 10-14 weeks |
| Description | SLLK, the control peptide for the TSP1 inhibitor, serves as the counterpart to LSKL. |
| In vivo | On day 42, the plasma TGF-β1 level in mice administered with LSKL is considerably lower (0.10±0.01 pg/mL) than in those treated with the SLLK control peptide (0.20±0.02 pg/mL; P=0.0001). The mRNA levels are evaluated in the suprarenal aortic lysates of mice given SLLK and LSKL peptides. Additionally, Akita mice treated with 30 mg/kg of LSKL show a more than twofold increase in nephrin expression in renal lysates compared to both saline controls and SLLK-treated mice. |
| Molecular Weight | 458.60 |
| Formula | C21H42N6O5 |
| Cas No. | 2918768-29-1 |
| Smiles | [C@@H](NC([C@@H](NC([C@H](CO)N)=O)CC(C)C)=O)(C(N[C@@H](CCCCN)C(N)=O)=O)CC(C)C |
| Storage | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.